Europe Clinical Laboratory Tests Market Size & Outlook
Europe clinical laboratory tests market, 2018-2030 (US$M)
Related Markets
Europe clinical laboratory tests market highlights
- The Europe clinical laboratory tests market generated a revenue of USD 24,153.4 million in 2023.
- The market is expected to grow at a CAGR of 10.1% from 2024 to 2030.
- In terms of segment, hba1c tests was the largest revenue generating type in 2023.
- HGB/HCT tests is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 24,153.4 million |
| Market revenue in 2030 | USD 47,295.2 million |
| Growth rate | 10.1% (CAGR from 2023 to 2030) |
| Largest segment | Hba1c tests |
| Fastest growing segment | HGB/HCT tests |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.1% of the global clinical laboratory tests market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 49,664.3 million by 2030.
Hba1c tests was the largest segment with a revenue share of 12.35% in 2023. Horizon Databook has segmented the Europe clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held the second-largest share of the clinical laboratory tests market due to presence of major research institutes and market players operating in the region. Moreover, favorable initiatives undertaken by the government and other nonprofit organizations to provide funds for R&D activities and create awareness about the benefits of early disease diagnosis are expected to boost market growth.
Chronic diseases, such as cardiovascular, cancer, respiratory disease, diabetes, and stroke, account for 77% of the total disease burden and 86% of all regional deaths. For instance, in Europe, around 3.9 million people die due to cardiovascular diseases every year, and around 29 million people suffer from a chronic liver condition, which is also a major cause of death in Europe.
Several initiatives undertaken by government and private organizations to fund R&D about clinical laboratory tests & services and create awareness about the benefits of early diagnosis are expected to boost the Europe clinical laboratory tests market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe clinical laboratory tests market size, by country, 2018-2030 (US$M)
Europe Clinical Laboratory Tests Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
